Durect Stock (NASDAQ: DRRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 18.000 / 218.496K |
Day Range | - - - |
52 Wk Range | 0.470 - 7.460 |
Market Cap | $39.672M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 3.71% |
Days to Cover | 4.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Durect (NASDAQ: DRRX) through any online brokerage.
Other companies in Durect’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), SCYNEXIS (NASDAQ:SCYX) and CalciMedica (NASDAQ:CALC).
The latest price target for Durect (NASDAQ: DRRX) was reported by JonesTrading on Thursday, November 9, 2023. The analyst firm set a price target for 0.00 expecting DRRX to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Durect (NASDAQ: DRRX) is $1.33 last updated March 27, 2024 at 7:47 PM EDT.
There are no upcoming dividends for Durect.
Durect’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Durect.
Durect is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.